Measurement of Arsenic Relative Bioavailability in Swine

被引:32
作者
Brattin, William [1 ]
Casteel, Stan [2 ]
机构
[1] SRC Inc, Denver, CO 80465 USA
[2] Univ Missouri, Coll Vet Med, Vet Med Diagnost Lab, Columbia, MO USA
来源
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES | 2013年 / 76卷 / 07期
基金
美国国家环境保护局;
关键词
URINARY-EXCRETION; METABOLITES;
D O I
10.1080/15287394.2013.771562
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This study describes a method for measuring the relative oral bioavailability (RBA) of arsenic (As) in soil and other soil-like media using young swine as the animal model. Groups of animals are exposed to site soil or sodium arsenate orally for 12 d. Forty-eight-hour urine samples were collected from each animal on d 67, 89, and 1011 and were analyzed for total As. The urinary excretion fraction (UEF) for each group was estimated by plotting the mass of As excreted in urine by each animal as a function of the dose administered, and then fitting a linear model to the data using simultaneous weighted linear regression. The RBA of a test material is calculated as the ratio of the UEF value for the test material divided by the UEF of the reference material. Uncertainty around the RBA estimate is calculated using Fieller's theorem. Application of this method to a series of test soils indicates that RBA values for As can range from 18 to 52%. This wide variability supports the conclusion that there may be important differences in RBA between sites, and that use of a site-specific RBA value is likely to increase the accuracy of risk estimates for exposure to As in soil.
引用
收藏
页码:449 / 457
页数:9
相关论文
共 10 条
  • [1] [Anonymous], 1998, Applied Regression Analysis
  • [2] Relative Bioavailability and Bioaccessibility and Speciation of Arsenic in Contaminated Soils
    Bradham, Karen D.
    Scheckel, Kirk G.
    Nelson, Clay M.
    Seales, Paul E.
    Lee, Grace E.
    Hughes, Michael F.
    Miller, Bradley W.
    Yeow, Aaron
    Gilmore, Thomas
    Serda, Sophia M.
    Harper, Sharon
    Thomas, David J.
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2011, 119 (11) : 1629 - 1634
  • [3] URINARY-EXCRETION OF INORGANIC ARSENIC AND ITS METABOLITES AFTER REPEATED INGESTION OF SODIUM METAARSENITE BY VOLUNTEERS
    BUCHET, JP
    LAUWERYS, R
    ROELS, H
    [J]. INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 1981, 48 (02) : 111 - 118
  • [4] COMPARISON OF THE URINARY-EXCRETION OF ARSENIC METABOLITES AFTER A SINGLE ORAL DOSE OF SODIUM ARSENITE, MONOMETHYLARSONATE, OR DIMETHYLARSINATE IN MAN
    BUCHET, JP
    LAUWERYS, R
    ROELS, H
    [J]. INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 1981, 48 (01) : 71 - 79
  • [5] Finney DJ, 1978, STAT METHODS BIOL AS
  • [6] BIOMONITORING FOR ENVIRONMENTAL EXPOSURES TO ARSENIC
    Orloff, Kenneth
    Mistry, Ketna
    Metcalf, Susan
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (07): : 509 - 524
  • [7] Measurement of arsenic bioavailability in soil using a primate model
    Roberts, SM
    Weimar, WR
    Vinson, JRT
    Munson, JW
    Bergeron, RJ
    [J]. TOXICOLOGICAL SCIENCES, 2002, 67 (02) : 303 - 310
  • [8] Relative oral bioavailability of arsenic from contaminated soils measured in the cynomolgus monkey
    Roberts, Stephen M.
    Munson, John W.
    Lowney, Yvette W.
    Ruby, Michael V.
    [J]. TOXICOLOGICAL SCIENCES, 2007, 95 (01) : 281 - 288
  • [9] US EPA, 2012, OSWER 9200.1-113
  • [10] WEIS C P, 1991, Chemical Speciation and Bioavailability, V3, P113